Trial Profile
Clinical Trials Insight: 700045819
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2009
Price :
$35
*
At a glance
- Drugs Atreleuton (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Myocardial infarction
- Focus Therapeutic Use
- Sponsors VIA Pharmaceuticals
- 16 Jun 2009 New trial record.